Skip to main content
Annals of Family Medicine logoLink to Annals of Family Medicine
. 2023 Jul-Aug;21(4):347–357. doi: 10.1370/afm.2985

Joint Display of Integrated Data Collection for Mixed Methods Research: An Illustration From a Pediatric Oncology Quality Improvement Study

C Nathan Nessle 1,, Lauren V Ghazal 2, Sung W Choi 1, Michael D Fetters 3
PMCID: PMC10365872  PMID: 37487720

Abstract

PURPOSE

Researchers often struggle to integrate quantitative and qualitative data. Joint displays of data collected using mixed methods provide a framework for supporting integration, yet the literature lacks methodologic articles illustrating in detail the iterative nature of constructing such displays. We demonstrate the process for creating a joint display for integrating the collection of data obtained by qualitative and quantitative methods.

METHODS

Within a convergent mixed methods cohort study, the Early Discharge of Febrile Neutropenic Children with Cancer Study, we constructed a joint display to inform integrated collection of 2 forms of data (quantitative and qualitative) from 2 sources (a patient-caregiver mixed methods survey and a manual abstraction of medical records).

RESULTS

In a first step, we used a data sources table to align related quantitative and qualitative data. The resulting table consisted of 2 side-by-side columns based on the mixed survey data. After several additional iterative steps, we constructed a final 6-column joint display. This final display delineated the separate data sources, linked constructs to the quantitative and qualitative variables within each source, and integrated the constructs across the separate data sources.

CONCLUSIONS

Challenges of integration, though not unique to prospective mixed methods cohort studies, stem from the sheer volume of qualitative and quantitative information and the need to logically organize the data in preparation for integrated data analysis. Tailoring joint displays to specific studies is challenging, but mixed methods researchers who embrace the methodologic malleability can produce effective joint displays to illustrate the mixed data collection linkages and create a preliminary structure ultimately for organizing mixed data findings.

Key words: febrile neutropenia, mixed methods integration, qualitative research, quantitative research, methodological studies, data display, pediatric cancer, research design, study planning, supportive care

INTRODUCTION

Pivotal to mixed methods research is integrating the findings and conveying meta-inferences, that is, interpreting the mixed data findings.1 In less than a decade, the creation of joint displays has emerged as a powerful tool to plan integrated data collection, conduct mixed qualitative and quantitative data analyses,2 and illuminate, in final published form, the complex interactions, relationships, and merging of the qualitative and quantitative data.3 Miles and Huberman4 first described joint displays, alternatively termed joint matrix or integration displays,5 as overall visual presentations of merged quantitative and qualitative data. These tables or figures serve as powerful tools that enable investigators to convey the complex relationships between qualitative and quantitative data. The rigor of mixed methods research can be compromised, however, if researchers inadequately plan for integrated data collection, a situation that may result from knowledge gaps surrounding contemporary methodologic literature on mixed methods.6 Across disciplines, joint displays have proven to be an effective tool for various objectives in mixed methods integration.7-10

Joint Displays for Presenting Findings

Joint displays are largely known for their use in presenting findings, and since the emergence of joint displays in the mixed methods literature, several researchers have made important additions to the process.7,8,11-14 The joint display can give depth and magnitude of related findings and provide the key context for explaining the why and how of the quantitative or qualitative data.1,5 Joint displays of findings show quantitative and qualitative data alongside each other, merging, connecting, or building together these results.1,5 The most common joint display format is a side-by-side display of quantitative and qualitative data.9

Joint Displays for Analyzing Data

More recently, joint displays have been identified as tools for analyzing mixed data.15-17 When used for this objective, they facilitate discovery of previously unforeseen linkages between the quantitative and qualitative data.7,13 Plano Clark18 highlighted that an overlooked value of joint displays is the analytic and integrative thinking critical to creating the visual displays. In an example of the use of joint display analysis from empirical work to add technology in the classroom, Haynes-Brown and Fetters19 provided details on their process of mixed data analysis in an explanatory sequential mixed methods study design, showing how a novel joint display was built and interpreted. Fetters and Guetterman15 provided a detailed accounting of how they created a series of joint displays to optimize both understanding of the mixed data results and presentation of the mixed data findings.

Joint Displays for Integrating Data Collection

A third application of joint displays, use for integrated data collection, ironically originated chronologically earlier than the aforementioned applications that debuted first in the published literature.7 Joint displays of integrated data collection depict in a table or figure the linkage of qualitative and quantitative data collection across common constructs or domains. By linking in this way, investigators can prepare for an integrated mixed data analysis.

In a recent review, Guetterman et al9 systematically examined joint display features in 33 articles across disciplines. They reported health sciences were most likely to use joint displays, although other disciplines (eg, education, social sciences, psychology, nursing) also used them in their studies. They delineated the important attributes of successful joint displays of results; however, the recommended attributes for joint displays of data collection were only a minor focus. Although some researchers have alluded to joint displays of integrated data collection,7,10,17 Fetters and Tajima3 published the first article dedicated to describing these displays. Although recommending joint displays of integrated data collection as a highly effective, yet underused tool that researchers could use to organize, plan, and represent their mixed methods studies, the authors did not provide an example of how to build these displays.

With the growing use of joint displays for data collection and analysis among mixed methods researchers,10 detailed examples of constructing joint displays of integrated data collection are needed. In this article, we illustrate the iterative process of creating a joint display for integrated collection of mixed methods data using the example of a prospective cohort study of febrile neutropenia among pediatric oncology patients. We detail the methodologic approach taken through iterative steps, describe the construction of the joint display of integrated data collection for the study, and identify its features and their utility.

METHODS

Primary Study

Our primary study was the Early Discharge of Febrile Neutropenic Children With Cancer Study. Febrile neutropenia, defined as a fever exceeding 38°C for more than an hour or a single fever exceeding 38.3°C in the setting of severe neutropenia with a neutrophil count of less than 500/μL,20 is an emergency in the oncology population associated with increased risk for infection and associated complications.21 Although most pediatric oncology patients are seen frequently by their primary oncologist, many maintain continuity of care with their primary care physician, allowing for the opportunity for collaborative management and anticipatory guidance. The study was a prospective quality improvement study, aimed to implement early inpatient discharge among pediatric oncology patients with low-risk febrile neutropenia episodes using a clinical decision risk tool21 in combination with serial procalcitonin levels.22

The study followed a convergent mixed methods design, which features synchronous quantitative and qualitative data collection and analysis.23,24 During the planning phase, we developed a mixed methods data sources table, which identified 2 separate data sources in the study: a patient-caregiver mixed methods survey and the clinical course obtained by manual abstraction of the medical record (Supplemental Table 1). Ethical approval from the University of Michigan Institutional Research Board was received in November 2021.

Date Sources

Mixed Methods Survey

The primary aim of the patient-caregiver mixed methods survey was to engage the patient-caregiver dyads in the quality improvement initiative by assessing quality of life and patient-reported outcomes associated with febrile neutropenia. The questionnaire used was a modified version of an original instrument,25 initially used to compare the quality of life measures of patient-caregiver dyads receiving inpatient or outpatient therapy for febrile neutropenia.26 We modified the quantitative questions with a Likert scale of “far below average” to “far above average” and expanded the abbreviated question items to the full questionnaire item. Qualitative questions were added to elucidate data that would expand on the constructs synergistically with the quantitative questions, and numerically organized within the instrument in close proximity to the corresponding quantitative question. The Cronbach α reliability coefficient was 0.782, confirming adequate internal reliability.27

Medical Record Abstraction

In addition to collecting information on febrile neutropenia episodes with the mixed methods survey, we performed a manual medical record abstraction of all episodes that met inclusion criteria for analysis. The aim of collecting these clinical data was to compare febrile neutropenia episodes by their risk assignment, assessing overall safety of early hospital discharge in the cases of low-risk episodes. This abstraction similarly yielded both quantitative and qualitative data.

Planning for Integration of Study Data

Considerable volumes of quantitative and qualitative data would be collected from both the survey and the medical record abstraction. We thus identified the need to better organize these data sources to link the data collection procedures. This approach would enable us to merge the 2 forms of data (quantitative and qualitative) based on matching the constructs held in common. We chose to develop a joint display of data collection based on existing literature3,17 but soon recognized construction of this table would require multiple iterations to fully organize integrated data collection. We ultimately used a methodologic process with 4 iterations to develop the final joint display of integrated data collection. During this process, the named descriptions of each data source (the survey and medical record abstraction) evolved and became more refined. For the purpose of clarity, however, we maintain the original names here.

RESULTS

Methodologic Approach

Our study team identified quantitative and qualitative variables within both the patient-caregiver survey and the clinical data from the manual abstraction of medical records. Following procedures illustrated by Fetters,17 we constructed a mixed methods data sources table (Supplemental Table 1), the imperative primary step that stimulated the subsequent iterative process. We then developed, reformatted, and refined our joint display through 4 iterations, ultimately arriving at the display used in the study.

Iteration 1: Developing a 2-Column Joint Display

Process

Building on the mixed methods data sources table, we constructed a side-by-side structured joint display table with 2 columns, separating the quantitative survey questions with a Likert scale from the qualitative open-ended survey questions (Table 1). Abbreviated question items from the survey were added for clarity and categorized by construct of best fit. A theoretical framework for the study, informed by the patient-caregiver survey, identified 6 constructs for the study: role functioning, emotional functioning, cognitive functioning, social functioning, symptoms, and global functioning.28

Table 1.

Iteration 1: Developing a 2-Column Joint Display

Quantitative Questions Qualitative Questions
Role functioning
  1. Keep up with household tasks. Scale 0-10; not at all–usual

  2. Confidence in ability to care for child. Scale 0-10; no confidence–very confident

  3. Independence. Scale 0-10; very clingy–as usual

  1. What is it like caring for your child when they are ill?

  2. What are the extra resources and help required to keep your family functioning during fever neutropenia episodes?

Emotional functioning
  1. Level of concern about child’s condition. Scale 0-10; very anxious–very calm

  2. Confidence in ability to care for child. Scale 0-10; no confidence–very confident

  3. Satisfaction with overall care. Scale 0-10; very unhappy–very happy

  4. Mood. Scale 0-10; very upset–very happy

  1. How has your child’s illness emotionally affected you?

Cognitive functioning
  1. Interest or concentration. Scale 0-10; not as usual–as usual

  2. Sleep at night. Scale 0-10; much worse–as usual

  3. Activity or energy level. Scale 0-10; not at all–most of the time

  1. Will you describe how school and work have been affected by your child’s illness?

Social functioning
  1. Spend time with partner. Scale 0-10; not at all–usual

  2. Spend time with other children. Scale 0-10; not at all–usual

  1. How has your child’s illness affected members in your family?

Symptoms
  1. Appetite. Scale 0-10; very poor–very good

  1. How are symptoms different when you are at home versus in the hospital?

Global
  1. Well-being. Scale 0-10; very poor–very good

  1. In your opinion, what value listed above is most important to you?

  2. Is there anything else you would like to share about caring for your child during fever neutropenia?

Impressions

This first iteration clearly communicated the appropriate constructs for the quantitative and qualitative variables found within the patient-caregiver survey. At this critical junction, we compared this first iteration (Table 1) with the mixed methods data sources table (Supplemental Table 1) and noted the need for greater comprehensiveness; data from the second source, the medical record abstraction, were not included. We subsequently began to iteratively reorganize the display to comprehensively integrate the quantitative and qualitative variables from both sources. We recognized the value of this joint display; in the mixed methods analysis, it could assist us in eventually linking related findings across related constructs and identifying meta-inferences from the 2 data sources.

On a reflective note, one author with limited experience in mixed methods research (C.N.N.) found it challenging to learn the basic development of a joint display table and felt bound by implied restrictive descriptions of developing such displays. Similarly, another author (L.V.G.), a clinician (nurse) and researcher, although trained in mixed methods designs during her dissertation work, felt uncertain about the process because of the lack of literature depicting illustrations of joint displays using multiple data sources.

Iteration 2: Incorporating Variables From Record Abstraction

Process

The second iteration (Table 2) represented our first attempt to incorporate the quantitative and qualitative clinical course variables from the medical records in the established 2-column, joint display table. This display proved difficult to organize clearly because of the large volume of information and complexity. It was not obvious how to integrate the clinical course variables. We shaded the constructs and itemized the variables to improve organization, but the resulting display still fell short of conveying the fact that the data would originate from distinct sources.

Table 2.

Iteration 2: Incorporating Variables From Record Abstraction

Quantitative Questions and Data Qualitative Questions and Data
Role functioning
  • Keep up with household tasks. Scale 0-10; not at all–usual

  • Confidence in ability to care for child. Scale 0-10; no confidence–very confident

  • Independence. Scale 0-10; very clingy–as usual

  • Hospital LOS

  • Readmission


Demographics
  • Age

  • Gender

  • Ethnicity


Episode characteristics
  • Clinical dx or MDI diagnosed? (URI, UTI, fungal, C diff, BSI, typhlitis, etc)

What is it like caring for your child when they are ill?
What are the extra resources and help required to keep your family functioning during fever neutropenia episodes?
Risk stratification:
  • High or low risk at presentation

  • High or low risk after 1 night’s observation


Type of outpatient FU (VR vs in-person)
Emotional functioning
  • Level of concern about child’s condition. Scale 0-10; very anxious–very calm

  • Confidence in ability to care for child. Scale 0-10; no confidence–very confident

  • Satisfaction with overall care. Scale 0-10; very unhappy–very happy

  • Mood. Scale 0-10; very upset–very happy


Oncologic history
  • Primary diagnosis

  • Date of diagnosis

  • Phase of therapy

  • Disease status


Demographics
  • Age

  • Gender

  • Ethnicity


Episode characteristics
  • Clinical dx or MDI diagnosed? (URI, UTI, fungal, C diff, BSI, typhlitis, etc)

How has your child’s illness emotionally affected you?
Discharge/follow-up description:
  • Type of follow-up (telephone, video, clinic)

  • Who did follow-up visits (RN, NP, fellow, attending)?

  • Frequency

  • RN, parent, clinician concerns documented

Cognitive functioning
  • Interest or concentration. Scale 0-10; not as usual–as usual

  • Sleep at night. Scale 0-10; much worse–as usual

  • Activity or energy level. Scale 0-10; not at all–most of the time


PICU admission
  • LOS ≤3 days

  • Acute respiratory failure present

  • Need for advanced airway

  • NIPPV or HFNC?

  • Need for pressor support


Is activity level affected by persistent N/V, typhlitis, need for IV narcotics, longer-length antibiotics, LOS?
Will you describe how school and work have been affected by your child’s illness?
PICU admission:
  • Related to FN

  • Noninfectious concern

  • Disease status

  • Evidence of shock


Risk stratification:
  • High or low risk at presentation

  • High or low risk after 1 night’s observation

Social functioning
  • Spend time with partner. Scale 0-10; not at all–usual

  • Spend time with other children. Scale 0-10; not at all–usual


Hospital LOS
Readmission
How has your child’s illness affected members in your family?
Type of outpatient FU (VR vs in-person)
Symptoms
  • Appetite. Scale 0-10; very poor–very good


Persistent N/V or C diff present?
How are symptoms different when you are at home versus in the hospital?
Evidence of mucositis or typhlitis?
Severe pain with IV narcotic requirement
Global
  • Well-being. Scale 0-10; very poor–very good

  • Hospital LOS

  • Readmission

  • PICU admission, LOS


Oncologic history
  • Primary diagnosis

  • Disease status

In your opinion, what value listed above is most important to you?
Is there anything else you would like to share about caring for your child during fever neutropenia?
Risk stratification:
  • High or low risk at presentation

  • High or low risk after 1 night’s observation

BSI = bloodstream infection; C diff = Clostridioides difficile; dx = diagnosis; FN = febrile neutropenia; FU = follow-up; HFNC = high-flow nasal cannula; IV = intravenous; MDI = microbiologically documented infection; NIPPV = noninvasive positive pressure ventilation; NP = nurse practitioner; N/V = nausea/vomiting; PICU = pediatric intensive care unit; RN = registered nurse; URI = upper respiratory infection; UTI = urinary tract infection; VR = virtual.

Note: Table footnotes have been added to improve clarity and readability. They were notably absent in the original tables.

Impressions

Although the overall structure and organization were consistent with those of the prior iteration, this second iteration (Table 2) now included the quantitative and qualitative variables from both the patient-caregiver survey and the medical record abstraction. Yet, this iteration did not succeed in depicting how mixed methods data in the study would arise from 2 separate sources. The constructs and linkage of each construct to both the quantitative and qualitative variables were not clear. Additionally, this format felt somewhat chaotic, and the patient-caregiver survey items were not apparent in the new depictions of the list of variables.

After this second iteration of the joint display table, we realized the established 2-column format of the joint display of data collection for the study would not sufficiently portray that the data came from separate sources. We reflected on a critical question at this juncture: were joint display table structures malleable to be different, or would it be more effective to have separate tables for each data source? The junior investigator for the febrile neutropenia study (C.N.N.) was uncertain about the iterative process in joint display table development and was concerned about achieving a joint display that could be used for the study.

Iteration 3: Expanding the Joint Display by Data Sources

Process

Building on the second iteration, which incorporated clinical course variables abstracted from medical records, the third iteration (Table 3) focused on separating the data sources: the patient-caregiver survey and the medical record abstraction. To improve the organization while retaining the construct rows, we added 2 columns to include the quantitative and qualitative variables from each source; for example, quantitative and qualitative survey questions were now in unique columns. We also added a clear title to the table to appropriately describe the integration of variables from different sources, changing the shading with formatting edits.

Table 3.

Iteration 3: Expanding the Joint Display by Data Sources

Joint Display of Integrated Mixed Methods Data Collection
Construct Quantitative Questions From Patient-Caregiver Survey Qualitative Questions From Patient-Caregiver Survey Quantitative Clinical Variables From Medical Record Abstraction Qualitative Clinical Variables From Medical Record Abstraction
Role Functioning Keep up with household tasks. Scale 0-10; not at all–usual
Confidence in ability to care for child. Scale 0-10; no confidence–very confident
Independence. Scale 0-10; very clingy–as usual
What is it like caring for your child when they are ill?
What are the extra resources and help required to keep your family functioning during fever neutropenia episodes?
Hospital LOS readmission demographics:
  • Age

  • Gender

  • Ethnicity


Episode characteristics
  • Clinical dx or MDI diagnosed? (URI, UTI, fungal, C diff, BSI, typhlitis, etc)

Risk stratification:
  • High or low risk at presentation

  • High or low risk after 1 night’s observation


Type of outpatient FU (VR vs in-person)
Emotional Functioning Level of concern about child’s condition. Scale 0-10; very anxious–very calm
Confidence in ability to care for child. Scale 0-10; no confidence–very confident
Satisfaction with overall care. Scale 0-10; very unhappy–very happy
Mood. Scale 0-10; very upset–very happy
How has your child’s illness emotionally affected you? Oncologic history:
  • Primary diagnosis

  • Date of dx

  • Phase of therapy

  • Disease status


Demographics:
  • Age

  • Gender

  • Ethnicity


Episode characteristics
  • Clinical dx or MDI diagnosed? (URI, UTI, fungal, C diff, BSI, typhlitis, etc)

Discharger/follow-up description:
  • Type of follow-up (phone, video, clinic)

  • Who did follow up visits (RN, NP, fellow, attending)?

  • Frequency

  • RN, parent, provider concerns documented

Cognitive Functioning Interest or concentration. Scale 0-10; not as usual–as usual
Sleep at night. Scale 0-10; much worse–as usual
Activity or energy level. Scale 0-10; not at all–most of the time
Will you describe how school and work have been affected by your child’s illness? PICU admission:
  • LOS ≤3 days

  • Acute respiratory failure present

  • Need for advanced airway

  • NIPPV or HFNC?

  • Need for pressor support


Is activity level affected by persistent N/V, typhlitis, need for IV narcotics, longer-length antibiotics, LOS?
PICU admission:
  • Related to FN

  • Noninfectious concern

  • Disease status

  • Evidence of shock


Risk stratification:
  • High or low risk at presentation

  • High or low risk after 1 night’s observation

Social Functioning Spend time with partner. Scale 0-10; not at all–usual
Spend time with other children. Scale 0-10; not at all–usual
How has your child’s illness affected members in your family? Hospital LOS
Readmission
Type of outpatient FU (VR vs in-person)
Symptoms Appetite. Scale 0-10; very poor–very good How are symptoms different when you are at home versus in the hospital? Persistent N/V or C diff present? Evidence of mucositis or typhlitis?
Severe pain w/ IV narcotic requirement
Global Well-being. Scale 0-10; very poor–very good In your opinion, what value listed above is most important to you?
Is there anything else you would like to share about caring for your child during fever neutropenia?
Hospital LOS
Readmission
PICU admission, LOS
Oncologic history:
  • Primary diagnosis

  • Disease status

Risk stratification:
  • High or low risk at presentation

  • High or low risk after 1 night’s observation

BSI = bloodstream infection; C diff = Clostridioides difficile; dx = diagnosis; FN = febrile neutropenia; FU = follow-up; HFNC = high-flow nasal cannula; IV = intravenous; LOS = length of stay; MDI = microbiologically documented infection; NIPPV = noninvasive positive pressure ventilation; NP = nurse practitioner; N/V = nausea/vomiting; PICU = pediatric intensive care unit; RN = registered nurse; URI = upper respiratory infection; UTI = urinary tract infection; VR = virtual; w/ = with.

Note: Table footnotes have been added to improve clarity and readability. They were notably absent in the original tables.

Although the quantitative and qualitative variables from each source were now in unique columns, the separate data sources between the patient-caregiver survey and the medical record abstraction were not well delineated. Labeling the columns with respective names helped indicate different data sources in the fully integrated table. As the table now was wider, with 2 additional columns, the linking of constructs was again lost across the table rows; therefore, we added another column on the left of the table to specify the construct found in each row. This change highlighted the integrated organization of variables within the individual constructs.

Impressions

The revised 5-column third iteration (Table 3) showed the various constructs as they related to the unique quantitative and qualitative variables from each source and seemed to better delineate between the data sources. Although the theoretical framework for the study was informed by the survey instrument, a focus of this iteration was to show the relationship of a construct to both types of data within both sources. This iteration also demarcated the integration of the mixed methods variables across each source. Despite the improved organization with the additional columns, the abbreviated survey question items now did not appear to provide enough information to justify the organizational rationale, and the clinical course variables from the medical records were not organized clearly within each construct row.

Although this iteration further improved on prior versions, with additional structuring and labels, additional organizational restructuring was needed. The desired message of the joint display table—how mixed methods data arising from separate data sources would be related—seemed to be clearer with this iteration than with previous iterations. There were, however, no comparable examples in the literature to affirm the adequacy of this structure. This version was shared with senior authors (S.W.C. and M.D.F.) for advice and clarity around a question that arose: would it be acceptable and effective to add more columns? Although the team was aided by senior mentorship, they had a persistent feeling that the expanded iteration of the joint display table was still incomplete.

Iteration 4: Refining Rationale and Organization in the Joint Display

Process

The focus of the fourth and final iteration of the joint display table of integrated data collection (Table 4) was to enhance the organizational rationale of the mixed methods variables and respective fit within each construct. This focus led to renaming and simplifying the column headers to communicate that the variables were clearly arising from separate sources: the patient-caregiver survey and the medical record abstraction. We removed abbreviations and short-hand terms from the clinical course variables to eliminate excessive detail from the abstraction and thereby better balance conciseness and text clarity.

Table 4.

Iteration 4: Refining Rationale and Organization in the Joint Display

Joint Display of Integrated Mixed Methods Data Collection
Construct Patient-Caregiver Mixed Methods Surveya Clinical Variables From Medical Record Abstraction Rationale of Organization (Example Questions)
Quantitative Questions Qualitative Questions Quantitative Clinical Variables Qualitative Clinical Variables
Role Functioning
  • 1.

    I can keep up with household tasks

  • 13.

    How would you describe your child’s level of dependence?

  • 9.

    What is it like caring for your child when they have fever neutropenia?

  • 2.

    What are the extra resources and help required to keep your family functioning during fever neutropenia episodes?

Admission characteristics:
  • Hospital LOS

  • Readmission

  • Episode characteristics

  • Was a cause of FN identified? If so, what?


Demographics:
  • Age, gender, ethnicity

Risk stratification:
  • High risk or low risk


Type of outpatient follow-up (virtual vs in-person)
Integration of data from clinical course and outcomes that may or may not impact caregiver role functioning within nuclear family (eg, Do caregivers with shorter LOS report improved role functioning?)
Emotional Functioning
  • 6.

    What is your overall level of concern for your child’s health and condition during this fever neutropenia episode?

  • 8.

    During this fever neutropenia episode, I am confident in my ability to care for my child.

  • 10.

    I am satisfied with the overall care my child received.

  • 12.

    How would you describe your child’s mood?

  • 7.

    How has your child’s illness emotionally affected you?

Oncologic history:
  • Primary diagnosis

  • Date of diagnosis

  • Phase of therapy

  • Disease status


Admission characteristics:
  • Hospital LOS

  • Readmission

  • Episode characteristics

  • Was a cause of FN identified? If so, what?


Demographics:
  • Age, gender, ethnicity

  • Episode characteristics

  • Was a cause of FN identified? If so, what?

Discharger/follow-up description:
  • Type of follow-up (telephone, video, clinic)

  • Who did follow-up visits (RN, NP, fellow, attending)?

  • Frequency of follow-up visits

  • RN, parent, provider concerns documented


Risk stratification:
  • High risk or low risk


Admission characteristics:
  • Hospital LOS

  • Readmission

  • PICU admission characteristics, LOS

Integration of data from clinical course and outcomes that may or may not impact caregiver and patient emotional functioning (eg, Do caregivers with a certain type of follow-up visit feel more confident in providing care?)
Cognitive Functioning
  • 16.

    How would you describe your child’s interest or concentration?

  • 18.

    How would you describe your child’s quality of sleep?

  • 19.

    How would you describe your child’s activity or energy level?

  • 17.

    How have school and work been affected by your child’s illness?

PICU admission:
  • LOS ≤3 days

  • Acute respiratory failure present

  • Need for advanced airway

  • NIPPV or HFNC?

  • Need for pressor support

PICU admission:
  • Related to FN

  • Noninfectious concern

  • Disease status

  • Evidence of shock


Risk stratification:
  • High risk or low risk

Integration of data from clinical course and outcomes that may or may not impact patient/caregiver perception of patient’s subjective measures of cognitive function (eg, Is activity level affected by persistent N/V, typhlitis, need for IV narcotics, longer length antibiotics, LOS?)
Social Functioning
  • 3.

    I am able to spend time with my partner

  • 4.

    I am able to spend time with my other children and/or family

  • 5.

    How did this fever neutropenia episode affect members in your family?

Admission characteristics:
  • Hospital LOS

  • Readmission

  • Episode characteristics

  • Was a cause of FN identified? If so, what?

Type of outpatient follow-up (virtual vs in-person) Integration of data from clinical course and outcomes that may or may not impact caregiver social functioning (eg, Were repeat trips back to the hospital or clinic more difficult for siblings?)
Symptom Severity
  • 14.

    How would you describe your child’s appetite?

  • 15.

    How are symptoms different when your child is at home versus in the hospital?

Persistent nausea, vomiting or C diff present?
Admission characteristics:
  • Hospital LOS

  • Readmission

  • Episode characteristics

  • Was a cause of FN identified? If so, what?

Evidence of mucositis or typhlitis?
Severe pain with IV narcotic requirement
Integration of data from clinical course and outcomes that may or may not impact subjective measures of symptom severity (eg, Do caregivers notice gastrointestinal problems impact their child’s appetite?)
Global Functioning
  • 11.

    What is your child’s overall happiness and well-being?

  • 20.

    In your opinion, what is the most important value when your child has fever neutropenia?

  • 21.

    Is there anything else you would like to share about caring for your child during fever neutropenia?

Admission characteristics:
  • Hospital LOS

  • Readmission

  • PICU admission, LOS


Oncologic history:
  • Primary diagnosis

  • Disease status

Risk stratification:
  • High risk or low risk


Admission characteristics:
  • Hospital LOS

  • Readmission

  • PICU LOS

Integration of data from clinical course and outcomes that may or may not impact the global perspective of care delivery (eg, Does a high-risk episode or a severe outcome impact a care-giver’s report of patient well-being?)

C diff = Clostridioides difficile; FN = febrile neutropenia; HFNC = high-flow nasal cannula; IV = intravenous; LOS = length of stay; NIPPV = noninvasive positive pressure ventilation; NP = nurse practitioner; N/V = nausea/vomiting; PICU = pediatric intensive care unit; RN = registered nurse.

a

Italics denote patient (vs caregiver) was focus of the question.

Note: Table footnotes have been added to improve clarity and readability. They were notably absent in the original tables.

We incorporated a sixth column on the right of the table that included example questions for each construct to explain the organizational structure and potential questions that could be answered with the mixed methods analysis. An example question within the role functioning construct was, “Do patient-caregiver dyads with shorter hospital length of stay report improved role functioning?” We expanded the abbreviated question items to the full, numbered items to further improve transparency for the rationale of the variables from separate data sources within each construct. This iteration would readily allow linking of sources after completing data collection, in anticipation of an integrated mixed methods analysis and result reporting. Finally, we italicized survey questions focusing on patients to distinguish them from those focusing on caregivers.

Impressions

This final iteration (Table 4) clearly communicated 2 central aspects of the study by conveying the primary linkage of the mixed data collection—how and why mixed methods variables from separate sources were related. It clarified that the study collected 2 types of data (quantitative and qualitative) from 2 separate sources by arranging the type from each source in a unique column. Additionally, this joint display table emphasized the organizational rationale of the variables across each construct by using the full survey items and example questions. Although it was somewhat arbitrary, we agreed this final iteration concisely and comprehensively described the data to be collected within the study. The end point for desisting from additional iterations was consensus that further organizational restructuring would not improve the depiction of integrated data collection.

DISCUSSION

As illustrated by our example, creating a joint display table of integrated data collection can entail an iterative process. Drawing from our experience, we created a series of steps for researchers to consider when creating a joint display of integrated data collection (Table 5). Through several iterations, we conveyed how quantitative and qualitative data collection from 2 separate data sources would be linked and provided a simple rationale for its organization. The primary step in developing the joint display of integrated data collection was to construct a comprehensive mixed methods data sources table (Supplemental Table 1). This process allowed the study team to clearly distinguish between the data sources and identify the qualitative and quantitative variables within each source, and eventually stimulated the iterative process to merge both data sources in the joint display. To clearly delineate that the variables arose from 2 separate sources, the sources and their respective mixed variables were placed in separate, unique columns in the joint display table, as this parallel arrangement was clearest for our group.

Table 5.

Steps for Creating a Joint Display of Integrated Data Collection

Step Description Researcher Considerations/Impressions
Step 1: Identify each distinct data source used in the study. This step requires a data sources template; an example can be found in the workbook by Fetters.17
Step 2: Within each data source, identify the quantitative and qualitative variables that will be collected. Valuate the variables obtained from each source, which may be best done when the sources are considered to be separate.
Step 3: Using a parallel arrangement, align the separate sources of data delineating between quantitative and qualitative variables within each source. Consider the example table structure to place the separate data sources. Each source should still be considered separate for this step.
Step 4: Identify the theory, model, or framework used in the study and link the quantitative and qualitative variables to the construct of best fit within each separate data source. Organizing by construct will ultimately allow for future integration. Some variables may fit in multiple constructs and could be placed in the best fit or in both locations. Determining a theory, model, or framework is explained by Varpio et al28 and Nilsen.29
Step 5: Taking the mixed variables now organized by construct, align and fit the constructs between each data source while adhering to an arrangement that communicates the separate sources. This step begins linking the variables from each source when organized by construct. Be sure the table structure still clearly delineates the sources.
Step 6: Apply example questions within each construct row using the linked mixed variables arranged by each source to further explain the organization rationale. This step links the separate sources and integrates the quantitative and qualitative variables. Example questions can be study outcomes or hypothetical examples to help explain the organizational rationale.

The next step in organizing the integrated joint display table incorporated the constructs from the theoretical framework used in the study analysis and assigned each variable to the most appropriate construct row. After the quantitative and qualitative variables were assigned to the construct of best fit, the variables could be arranged by construct within each data source column (ie, survey or record abstraction) in a manner that also effectively maintained a clear delineation between sources. The final step featured examples of questions to explain the organizational rationale of the constructs, mixed variables, and separate sources (ie, the variables within each source and the variables within specific constructs). This final column of Organizational Rationale allowed us to anticipate key linkages within each construct of the theoretical framework to consider at data analysis, after collection.

Methodologic Insight

This article expands the current mixed methods research literature in several ways. First, we provide a novel iteration of a joint display of integrated data collection that depicts how collection of data was planned from 2 related but separate sources (a patient-caregiver mixed methods survey and a manual abstraction of medical records) for a prospective cohort study. Second, this illustration highlights how a joint display of data collection lays the groundwork for a joint display analysis, and ultimately, a joint display of integrated findings.17 The theoretical framework and creation of the joint display of integrated data collection was a powerful process for anticipating and organizing the mixed methods analysis before data collection. For example, the joint display and the rationale provided within the role functioning construct informed the coding process, identified the mixed variables from each data source, and aided in identifying a major theme of “treatment location.” Third, although joint displays of data collection are used in other study designs,3,10 this example is the first illustration of use in a prospective cohort study, a common design in the health sciences. Fourth, our experience illustrates the malleability of an approach that began with a basic mixed methods data sources table and subsequently evolved into a sophisticated structure for conceptualizing many diverse sources of data. Future research can explore how our display arising from a convergent mixed methods design may be further adapted.

Finally, as a reflective insight of the iterative process, the junior investigators of the team were novices in the process, whereas the senior team members remained confident of an eventual outcome (ie, the development of a final joint display of integrated data collection both comprehensive and clear enough to be used in the study). Each step was incremental and reactive to the iterative changes, much as was the process reported by Haynes-Brown and Fetters19 in their creation of a joint display of integrated data findings. We hope this methodologic description will stimulate investigators to expand on the approach and to adapt or develop additional visual joint display structures that can be applied to other designs, such as the sequential exploratory and explanatory mixed methods designs, further described by others.3,9,16

Conclusions

Joint displays of integrated mixed methods data collection can convey complex relationships between quantitative and qualitative data. The joint display fully links the organization of the mixed data collection and lays the groundwork for subsequently conducting a mixed methods analysis conducive to producing meta-inferences. We hope our illustration will stimulate mixed methods researchers conducting prospective cohort studies with multiple mixed data sources to use similar joint displays of integrated data collection. We highlight the malleability of the process and encourage other researchers to creatively expand joint display structures to maximize their utility, not only for mixed methods cohort studies, but for other study designs as well.

Footnotes

Conflicts of interest: authors report none.

Funding support: Drs Nessle and Ghazal are supported by grant T32-CA236621, Interdisciplinary Research Training Center in Cancer Care Delivery, from the National Cancer Institute (NCI) of the National Institutes of Health (NIH). Dr Nessle is also supported by the Fogarty International Center and the NCI of the NIH under grant 3D43TW009345-11S4 awarded to the Northern Pacific Global Health Fellows Program. Dr Choi is supported by grant K24HL156896, which supports mentoring in patient-oriented research. Dr Fetters’ participation was made possible through support of the Mixed Methods Program, Department of Family Medicine, University of Michigan.

Disclaimer: The views expressed are solely those of the authors and do not necessarily represent official views of the authors’ affiliated institutions or funders.

References

  • 1.Fetters MD, Curry LA, Creswell JW.. Achieving integration in mixed methods designs-principles and practices. Health Serv Res. 2013; 48(6 Pt 2): 2134-2156. 10.1111/1475-6773.12117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Yin RK. Mixed methods research: are the methods genuinely integrated or merely parallel? Res in the Schools. 2006; 13(1): 41-47. [Google Scholar]
  • 3.Fetters MD, Tajima C.. Joint displays of integrated data collection in mixed methods research. Intl J Qual Methods. 2022; 21: 1-13. 10.1177/16094069221104564 [DOI] [Google Scholar]
  • 4.Miles MB, Huberman AM.. Qualitative Data Analysis: An Expanded Sourcebook, 2nd ed. Sage Publications, Inc; 1994. [Google Scholar]
  • 5.Creswell JW, Clark VLP.. Designing and Conducting Mixed Methods Research, 3rd ed. Sage Publications, Inc; 2017. [Google Scholar]
  • 6.Younas A, Pedersen M, Tayaben JL.. Review of mixed-methods research in nursing. Nurs Res. 2019; 68(6): 464-472. 10.1097/NNR.0000000000000372 [DOI] [PubMed] [Google Scholar]
  • 7.Guetterman TC, Fetters MD, Creswell JW.. Integrating quantitative and qualitative results in health science mixed methods research through joint displays. Ann Fam Med. 2015; 13(6): 554-561. 10.1370/afm.1865 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Johnson RE, Grove AL, Clarke A.. Pillar integration process: a joint display technique to integrate data in mixed methods research. J Mixed Methods Res. 2019; 13(3): 301-320. 10.1177/1558689817743108 [DOI] [Google Scholar]
  • 9.Guetterman TC, Fàbregues S, Sakakibara R.. Visuals in joint displays to represent integration in mixed methods research: a methodological review. Methods in Psychology. 2021; 5: 100080. 10.1016/j.metip.2021.100080 [DOI] [Google Scholar]
  • 10.McCrudden MT, Marchand G, Schutz PA.. Joint displays for mixed methods research in psychology. Methods in Psychology. 2021; 5: 100067. 10.1016/j.metip.2021.100067 [DOI] [Google Scholar]
  • 11.Happ MB, Dabbs AD, Tate J, Hricik A, Erlen J.. Exemplars of mixed methods data combination and analysis. Nurs Res. 2006; 55(2)(Suppl): S43-S49. 10.1097/00006199-200603001-00008 [DOI] [PubMed] [Google Scholar]
  • 12.Bazeley P. Integrating Analyses in Mixed Methods Research. Sage Publications Ltd; 2018. 10.4135/9781526417190 [DOI] [Google Scholar]
  • 13.Guetterman TC, Fetters MD.. Two methodological approaches to the integration of mixed methods and case study designs: a systematic review. Am Behav Sci. 2018; 62(7): 900-918. 10.1177/0002764218772641 [DOI] [Google Scholar]
  • 14.O’Cathain A, Murphy E, Nicholl J.. Three techniques for integrating data in mixed methods studies. BMJ. 2010; 341: c4587. 10.1136/bmj.c4587 [DOI] [PubMed] [Google Scholar]
  • 15.Fetters MD, Guetterman TC.. Development of joint display as mixed analysis. In: Onwuegbuzie AJ, Johonson RB, eds. The Routledge Reviewer’s Guide for Mixed Methods Analysis. Routledge; 2021: 259-276. [Google Scholar]
  • 16.Fetters MD, Guetterman TC.. Data visualization in the context of integrated analyses. In: Hitchcock JH, Onwuegbuzie AJ, eds. The Routledge Handbook for Advancing Integration in Mixed Methods Research. Routledge; 2022:301-323. [Google Scholar]
  • 17.Fetters MD. The Mixed Methods Research Workbook: Activities for Designing, Implementing, and Publishing Projects, 1st ed. Sage Publications, Inc; 2019. [Google Scholar]
  • 18.Plano Clark VL. Meaningful integration within mixed methods studies: identifying why, what, when, and how. Contemp Educ Psychol. 2019; 57: 106-111. 10.1016/j.cedpsych.2019.01.007 [DOI] [Google Scholar]
  • 19.Haynes-Brown TK, Fetters MD.. Using joint display as an analytic process: an illustration using bar graphs joint displays from a mixed methods study of how beliefs shape secondary school teachers’ use of technology. Int J Qual Methods. 2021; 20: 1609406921993286. 10.1177/1609406921993286 [DOI] [Google Scholar]
  • 20.Taplitz RA, Kennedy EB, Bow EJ, et al. Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update. J Clin Oncol. 2018; 36(14): 1443-1453. 10.1200/JCO.2017.77.6211 [DOI] [PubMed] [Google Scholar]
  • 21.Lehrnbecher T, Robinson P, Fisher B, et al. Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update. J Clin Oncol. 2017; 35(18): 2082-2094. 10.1200/JCO.2016.71.7017 [DOI] [PubMed] [Google Scholar]
  • 22.Nessle CN, Braun T, Choi SW, Mody R.. Internal evaluation of risk stratification tool using serial procalcitonin and clinical risk factors in pediatric febrile neutropenia: the non-interventional, single institution experience prior to clinical implementation. Pediatr Hematol Oncol. 2023: 40(2): 172-180. 10.1080/08880018.2022.2079785 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Morse JM. Evaluating qualitative research. Qual Health Res. 1991; 1(3): 283-286. 10.1177/104973239100100301 [DOI] [Google Scholar]
  • 24.Teddlie C, Tashakkori A.. Overview of contemporary issues in mixed methods research. In: Tashakkori A, Teddlie C, eds. SAGE Handbook of Mixed Methods in Social & Behavioral Research. Sage Publications, Inc; 2010:1-42. 10.4135/9781506335193 [DOI] [Google Scholar]
  • 25.Close P, Burkey E, Kazak A, Danz P, Lange B.. A prospective, controlled evaluation of home chemotherapy for children with cancer. Pediatrics. 1995; 95(6): 896-900. [PubMed] [Google Scholar]
  • 26.Orme LM, Babl FE, Barnes C, Barnett P, Donath S, Ashley DM.. Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: a randomised trial. Pediatr Blood Cancer. 2014; 61(8): 1427-1433. 10.1002/pbc.25012 [DOI] [PubMed] [Google Scholar]
  • 27.Gliem JA, Gliem RR.. Calculating, interpreting, and reporting Cronbach’s alpha reliability coefficient for likert-type scales. ScholarWorks. Published Jan 2003. Accessed Feb 15, 2023. https://scholarworks.iupui.edu/handle/1805/344
  • 28.Varpio L, Paradis E, Uijtdehaage S, Young M.. The distinctions between theory, theoretical framework, and conceptual framework. Acad Med. 2020; 95(7): 989-994. 10.1097/ACM.0000000000003075 [DOI] [PubMed] [Google Scholar]
  • 29.Nilsen P. Making sense of implementation theories, models and frameworks. Implement Sci. 2015; 10(1): 53. 10.1186/s13012-015-0242-0 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Family Medicine are provided here courtesy of Annals of Family Medicine, Inc.

RESOURCES